Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions
1,821 articles
A 2025 narrative review maps how regenerative medicine, epigenetics, AI, and microbiome science are transforming cosmetic dermatology.
A landmark 2025 review maps how gut bacteria shift across your lifespan and reveals therapies that could slow biological aging.
Vasa Therapeutics advances VS-214, a peptide targeting poor limb circulation, toward first human trials in 2026 — addressing a massively underserved condition.
A new webinar tackles the real question in NAD+ supplementation: whether pills, injections, or pens produce meaningfully different health outcomes.
Recent NIH-funded studies map pancreatic cells, improve heart risk prediction, and reveal testosterone's role in brain tumors.
New cohort data revises assumptions about US life expectancy gaps, showing near-universal gains for those born 1941–2000.
A newly characterized inner mitochondrial protein reshapes cristae structure, enhances energy output, and extends lifespan in transgenic flies.
A new study reveals how collapsing mitochondrial structure in kidney cells fuels oxidative stress and age-related kidney decline.
Scarlet Therapeutics grows universal red blood cells that survive as long as donated ones, opening a path to engineered therapeutic blood.
A landmark multi-omic study shows GLP-1 receptor agonists like semaglutide broadly reverse age-related molecular changes in aging mice.
Senescent cells leak mitochondrial RNA into the cytosol, triggering an antiviral response that fuels the inflammatory SASP and age-related disease.
Adult-onset adipocyte FGF21 overexpression extends lifespan up to 3.3 years in high-fat-diet mice, cutting inflammation and toxic lipids.
